Johnson & Johnson on Tuesday sued the Biden administration in a controversy over how it distributes rebates under the federal ...

It has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have lost about 6.7% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

(RTTNews) - Johnson & Johnson (JNJ), Thursday announced results from additional analyses of the Phase 2 DAHLIAS study, evaluating the effects of Nipocalimab in participants with primary Sjogren's ...

Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

Johnson & Johnson MedTech announced today that it entered into an exclusive commercial distribution agreement with Responsive Arthroscopy. The company agreed to a deal in the U.S. with Responsive ...

Angela Meady lives in Thunder Bay, Ontario where many Slovak people settled from the 1880s through 1950s. Angela has degrees in English Literature, Philosophy and Information Science and is director ...